🇺🇸 FDA
Pipeline program

Individualized caffeine cessation instructions

BPR01-05-04-03

Phase 1 other completed

Quick answer

Individualized caffeine cessation instructions for Self-identified Problematic Caffeine Use is a Phase 1 program (other) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Self-identified Problematic Caffeine Use
Phase
Phase 1
Modality
other
Status
completed

Clinical trials